Mae Fah Luang University Hospital   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Mueang Chiang Rai Thailand (2018)

Organization Overview

First Clinical Trial
2018
NCT01391156
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Mae Fah Luang University | Mae Fah Luang University Hospital (Bangkok) | Mae Fah Luang University Hospital(Bangkok)

Active Ingredients

Drugs in Phase 4 Trials (5)

bromhexine (1 trial)

cyproheptadine (periactin) (1 trial)

fluvoxamine (luvox) (1 trial)

minoxidil (loniten) (5 trials)

niclosamide (nicloside) (1 trial)

Drugs in Phase 3 Trials (1)

finasteride (Proscar) (1 trial)

Drugs in Phase 2 Trials (1)

hydroquinone (1 trial)

Drugs in Other Trials (1)

rimabotulinumtoxinB (Myobloc) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alopecia (Phase 3)

Alopecia Areata (Phase 3)

Hypotrichosis (Phase 4)

Melanosis (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 8